European copycat sector cheers IP reform efforts

Medicines for Europe, a trade group representing the generic and biosimilars sector in the region, has applauded efforts by the European Commission to improve the current intellectual property regime.

Referring to the European Parliament’s “Own-initiative” report, the group said the steps outlined by the EC represented “an important step to support the EU’s recovery and resilience following the pandemic and on equitable access to medicine.”

Regulatory reform